Indian Journal of Nuclear Medicine
Home | About IJNM | Search | Current Issue | Past Issues | Instructions | Ahead of Print | Online submissionLogin 
Indian Journal of Nuclear Medicine
  Editorial Board | Subscribe | Advertise | Contact
Users Online: 2163 Print this page  Email this page Small font size Default font size Increase font size

    Article Cited by others


A comparison study of 11 C-methionine and 18 F-fluorodeoxyglucose positron emission tomography-computed tomography scans in evaluation of patients with recurrent brain tumors

Sharma Rajnish, D«SQ»Souza Maria, Jaimini Abhinav, Hazari Puja Panwar, Saw Sanjeev, Pandey Santosh, Singh Dinesh, Solanki Yachna, Kumar Nitin, Mishra Anil K, Mondal Anupam

Year : 2016| Volume: 31| Issue : 2 | Page no: 93-102

   This article has been cited by
1 Imaging Advances for Central Nervous System Tumors
Raymond Y. Huang, Whitney B. Pope
Hematology/Oncology Clinics of North America. 2022; 36(1): 43
[Pubmed]  [Google Scholar] [DOI]
2 Neuro-Oncology Practice Clinical Debate: FDG PET to differentiate glioblastoma recurrence from treatment-related changes
Ephraim E Parent, Derek R Johnson, Tyler Gleason, Javier E Villanueva-Meyer
Neuro-Oncology Practice. 2021; 8(5): 518
[Pubmed]  [Google Scholar] [DOI]
3 Adult-onset medulloblastoma presenting with atypical MRI findings
Masashi Watanabe, Hitoshi Miki, Katsumi Kito, Shiro Ohue, Kensho Okamoto
Neurology and Clinical Neuroscience. 2021; 9(4): 342
[Pubmed]  [Google Scholar] [DOI]
4 Combined BNCT and PET for theranostics
Michal Silarski, Katarzyna Dziedzic-Kocurek, Monika Szczepanek
Bio-Algorithms and Med-Systems. 2021; 0(0)
[Pubmed]  [Google Scholar] [DOI]
5 Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of imaging in the management of progressive glioblastoma in adults
Derek Richard Johnson, Chad Allan Glenn, Ramin Javan, Jeffrey James Olson
Journal of Neuro-Oncology. 2021;
[Pubmed]  [Google Scholar] [DOI]
6 Diagnostic Accuracy of PET for Differentiating True Glioma Progression From Post Treatment-Related Changes: A Systematic Review and Meta-Analysis
Meng Cui, Rocío Isabel Zorrilla-Veloz, Jian Hu, Bing Guan, Xiaodong Ma
Frontiers in Neurology. 2021; 12
[Pubmed]  [Google Scholar] [DOI]
7 The Additional Value of 18F-FDG PET and MRI in Patients with Glioma: A Review of the Literature from 2015 to 2020
Natale Quartuccio, Riccardo Laudicella, Antonio Vento, Salvatore Pignata, Maria Vittoria Mattoli, Rossella Filice, Alessio Danilo Comis, Annachiara Arnone, Sergio Baldari, Manlio Cabria, Angelina Cistaro
Diagnostics. 2020; 10(6): 357
[Pubmed]  [Google Scholar] [DOI]
8 Diagnostic Accuracy of PET Tracers for the Differentiation of Tumor Progression from Treatment-Related Changes in High-Grade Glioma: A Systematic Review and Metaanalysis
Paul L. de Zwart, Bart R.J. van Dijken, Gea A. Holtman, Gilles N. Stormezand, Rudi A.J.O. Dierckx, Peter Jan van Laar, Anouk van der Hoorn
Journal of Nuclear Medicine. 2020; 61(4): 498
[Pubmed]  [Google Scholar] [DOI]
9 Amino acid PET and MR perfusion imaging in brain tumours
Christian P. Filss, Francesco Cicone, Nadim Jon Shah, Norbert Galldiks, Karl-Josef Langen
Clinical and Translational Imaging. 2017; 5(3): 209
[Pubmed]  [Google Scholar] [DOI]
10 The performance of 11C-Methionine PET in the differential diagnosis of glioma recurrence
Weilin Xu, Liansheng Gao, Anwen Shao, Jingwei Zheng, Jianmin Zhang
Oncotarget. 2017; 8(53): 91030
[Pubmed]  [Google Scholar] [DOI]


Read this article